Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Hirotaka Miyashita

Title(s)Assistant Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Emailhimiyashita@ucsd.edu
vCardDownload vCard

    Collapse Overview 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Predicting Skeletal-Related Events in Bone Metastasis from Advanced Breast Cancer Using Machine Learning. Clin Breast Cancer. 2026 Jan 12. Miyashita H, Aoshima K. PMID: 41720705.
      View in: PubMed   Mentions:    Fields:    
    2. Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations. J Clin Oncol. 2026 Mar; 44(7):540-552. Sicklick JK, Nishizaki D, Miyashita H, Okamura R, Hahn ME, Nikanjam M, Fanta PT, Piccioni DE, Patel H, Eskander RN, McKay RR, Ross JS, Lee JJ, Lippman SM, Kato S, Kurzrock R. PMID: 41505666; PMCID: PMC12931862.
      View in: PubMed   Mentions:
    3. Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System. Cancer Med. 2026 Jan; 15(1):e71467. Nikanjam M, Kato S, Nishizaki D, Miyashita H, Pabla S, Nesline MK, Ko H, Conroy JM, Naing A, Kurzrock R. PMID: 41474629; PMCID: PMC12755401.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    4. CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists. Cancer Immunol Immunother. 2025 Nov 03; 74(12):359. Uehara Y, Nishizaki D, Fujiwara Y, Miyashita H, Lee S, Pabla S, DePietro P, Ko H, Jensen TJ, Sicklick JK, Kato S, Kurzrock R. PMID: 41182434; PMCID: PMC12583269.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades. Immunotargets Ther. 2025; 14:967-977. Larkin B, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Eskander RN, Jensen TJ, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kurzrock R, Kato S. PMID: 40937367; PMCID: PMC12420428.
      View in: PubMed   Mentions:
    6. In vivo responses of β-tricalcium phosphate-based paste-like artificial bone with antibacterial properties under potentially infectious conditions using a rabbit model. J Mater Sci Mater Med. 2025 Aug 30; 36(1):70. Miyashita H, Kamaya Y, Suzuki K, Kato S, Morikawa S, Soma T, Nasu M, Munakata K, Nakagawa T, Aizawa M. PMID: 40884602; PMCID: PMC12398468.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    7. Navigating Ongoing Challenges in GI Stromal Tumors. Am Soc Clin Oncol Educ Book. 2025 06; 45(3):e473224. Joensuu H, Miyashita H, George S, Sicklick J. PMID: 40393024.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. 4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists. Cancer Commun (Lond). 2024 Oct; 44(10):1168-1172. Uehara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Pabla S, Conroy JM, DePietro P, Ko H, Sicklick JK, Kurzrock R. PMID: 39097973; PMCID: PMC11483270.
      View in: PubMed   Mentions: 1     Fields:    
    9. TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer. Am J Cancer Res. 2024; 14(5):2493-2506. Ahmed J, Nishizaki D, Miyashita H, Lee S, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S, Kurzrock R. PMID: 38859842; PMCID: PMC11162668.
      View in: PubMed   Mentions: 4  
    10. The transcriptomic expression pattern of immune checkpoints shows heterogeneity between and within cancer types. Am J Cancer Res. 2024; 14(5):2240-2252. Miyashita H, Bevins NJ, Thangathurai K, Lee S, Pabla S, Nesline MK, Glenn ST, Conroy JM, DePietro P, Rubin E, Sicklick JK, Kato S, Kurzrock R. PMID: 38859855; PMCID: PMC11162686.
      View in: PubMed   Mentions: 4  
    11. KRAS G12C inhibitor combination therapies: current evidence and challenge. Front Oncol. 2024; 14:1380584. Miyashita H, Kato S, Hong DS. PMID: 38756650; PMCID: PMC11097198.
      View in: PubMed   Mentions: 19  
    12. Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting. Am J Cancer Res. 2024; 14(4):1634-1648. Moussa P, Kurzrock R, Nishizaki D, Miyashita H, Lee S, Nikanjam M, Pabla S, Nesline MK, Ko H, Conroy JM, DePietro P, Sicklick JK, Kato S. PMID: 38726288; PMCID: PMC11076267.
      View in: PubMed   Mentions: 2  
    13. High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy. iScience. 2024 Apr 19; 27(4):109632. Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Conroy JM, DePietro P, Pabla S, Lippman SM, Kurzrock R. PMID: 38632994; PMCID: PMC11022045.
      View in: PubMed   Mentions: 6  
    14. OX40/OX40 ligand and its role in precision immune oncology. Cancer Metastasis Rev. 2024 Sep; 43(3):1001-1013. Thapa B, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Previs RA, Conroy JM, DePietro P, Pabla S, Kurzrock R. PMID: 38526805; PMCID: PMC11300540.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    15. Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. ESMO Open. 2024 Apr; 9(4):102942. Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S. PMID: 38503143; PMCID: PMC10966162.
      View in: PubMed   Mentions: 17  Translation:Humans
    16. High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome. Ther Adv Med Oncol. 2024; 16:17588359231220510. Krishnamurthy N, Nishizaki D, Lippman SM, Miyashita H, Nesline MK, Pabla S, Conroy JM, DePietro P, Kato S, Kurzrock R. PMID: 38188465; PMCID: PMC10771755.
      View in: PubMed   Mentions: 13  
    17. Combining EGFR and KRAS G12C Inhibitors for KRAS G12C Mutated Advanced Colorectal Cancer. J Cancer Immunol (Wilmington). 2024; 6(2):62-69. Miyashita H, Hong DS. PMID: 39175850; PMCID: PMC11340593.
      View in: PubMed   Mentions: 4  
    18. Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity. Cancer Med. 2024 01; 13(1):e6844. Lim J, Kurzrock R, Nishizaki D, Miyashita H, Adashek JJ, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman SM, Kato S. PMID: 38132831; PMCID: PMC10807558.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    19. Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy. Mol Cancer Ther. 2023 11 01; 22(11):1352-1362. Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline MK, Conroy JM, Rubin E, Eskander RN, Kurzrock R. PMID: 37619986; PMCID: PMC11347188.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy. NPJ Genom Med. 2023 Aug 08; 8(1):19. Miyashita H, Kurzrock R, Bevins NJ, Thangathurai K, Lee S, Pabla S, Nesline M, Glenn ST, Conroy JM, DePietro P, Rubin E, Sicklick JK, Kato S. PMID: 37553332; PMCID: PMC10409760.
      View in: PubMed   Mentions: 16  
    21. LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics. Cancer Med. 2023 06; 12(12):13155-13166. Adashek JJ, Kato S, Nishizaki D, Miyashita H, De P, Lee S, Pabla S, Nesline M, Conroy JM, DePietro P, Lippman S, Kurzrock R. PMID: 37132280; PMCID: PMC10315766.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    22. Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy. Res Sq. 2023 Feb 16. Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline M, Conroy J, Rubin E, Eskander R, Kurzrock R. PMID: 36824739; PMCID: PMC9949233.
      View in: PubMed   Mentions:
    23. First-line therapy for elderly patients with advanced renal cell carcinoma in the immuno-oncology era: a network meta-analysis. Cancer Immunol Immunother. 2023 Jun; 72(6):1355-1364. Fujiwara Y, Miyashita H, Liaw BC. PMID: 36495342; PMCID: PMC10991449.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Clinical usefulness of a novel classification of T cell distribution patterns in the tumor microenvironment of follicular lymphoma to detect transformation. Ann Hematol. 2022 Nov; 101(11):2477-2483. Miyashita H, Taoka K, Kume A, Ushiku A, Ushiku T, Toyama K, Kurokawa M. PMID: 36069932.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials. Cancer Immunol Immunother. 2022 Dec; 71(12):2837-2848. Fujiwara Y, Horita N, Harrington M, Namkoong H, Miyashita H, Galsky MD. PMID: 35471602; PMCID: PMC10992785.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    26. Bone-modifying agents for bone loss in patients with prostate cancer receiving androgen deprivation therapy; insights from a network meta-analysis. Support Care Cancer. 2022 Jan; 30(1):855-863. Miyashita H, Satoi S, Cruz C, Kim SM, Patel VG. PMID: 34392414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate. Support Care Cancer. 2022 Feb; 30(2):981-984. Miyashita H, Cruz C, Patel V. PMID: 34373957.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City. Int J Clin Pract. 2021 Jul; 75(7):e14261. Yamada T, Mikami T, Chopra N, Miyashita H, Chernyavsky S, Miyashita S. PMID: 34233397; PMCID: PMC8420601.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    29. An Evaluation of Serum 25-Hydroxy Vitamin D Levels in Patients with COVID-19 in New York City. J Am Nutr Assoc. 2022 02; 41(2):201-206. Gavioli EM, Miyashita H, Hassaneen O, Siau E. PMID: 33605826; PMCID: PMC7898298.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    30. Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis. Cardiovasc Diabetol. 2021 01 07; 20(1):14. Yamada T, Wakabayashi M, Bhalla A, Chopra N, Miyashita H, Mikami T, Ueyama H, Fujisaki T, Saigusa Y, Yamaji T, Azushima K, Urate S, Suzuki T, Abe E, Wakui H, Tamura K. PMID: 33413348; PMCID: PMC7792332.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    31. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer. J Thromb Thrombolysis. 2021 Jan; 51(1):102-111. Ueyama H, Miyashita H, Takagi H, Cruz C, Burger A, Briasoulis A, Kuno T. PMID: 32458316.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    32. Incidence and Risk of Colitis With Programmed Death 1 Versus Programmed Death Ligand 1 Inhibitors for the Treatment of Cancer. J Immunother. 2020 Nov/Dec; 43(9):291-298. Miyashita H, Mikami T, Satoi S, Cruz C, Galsky MD. PMID: 32960847.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. First-in-class humanized FSH blocking antibody targets bone and fat. Proc Natl Acad Sci U S A. 2020 11 17; 117(46):28971-28979. Gera S, Sant D, Haider S, Korkmaz F, Kuo TC, Mathew M, Perez-Pena H, Xie H, Chen H, Batista R, Ma K, Cheng Z, Hadelia E, Robinson C, Macdonald A, Miyashita S, Williams A, Jebian G, Miyashita H, Gumerova A, Ievleva K, Smith P, He J, Ryu V, DeMambro V, Quinn MA, Meseck M, Kim SM, Kumar TR, Iqbal J, New MI, Lizneva D, Rosen CJ, Hsueh AJ, Yuen T, Zaidi M. PMID: 33127753; PMCID: PMC7682550.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    34. Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City. HIV Med. 2021 01; 22(1):e1-e2. Miyashita H, Kuno T. PMID: 32829525; PMCID: PMC7461410.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    35. Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial. Support Care Cancer. 2021 Mar; 29(3):1629-1633. Miyashita H, Cruz C, Smith C. PMID: 32747990.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. Neo-adjuvant therapy for triple-negative breast cancer: Insights from a network meta-analysis. Breast J. 2020 09; 26(9):1717-1728. Miyashita H, Satoi S, Cruz C, Malamud SC. PMID: 32657479.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York. Geriatr Gerontol Int. 2020 Jul; 20(7):732-734. Miyashita S, Yamada T, Mikami T, Miyashita H, Chopra N, Rizk D. PMID: 32691924; PMCID: PMC7404346.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsPHPublic Health
    38. Risk Factors for Mortality in Patients with COVID-19 in New York City. J Gen Intern Med. 2021 01; 36(1):17-26. Mikami T, Miyashita H, Yamada T, Harrington M, Steinberg D, Dunn A, Siau E. PMID: 32607928; PMCID: PMC7325642.
      View in: PubMed   Mentions: 142     Fields:    Translation:HumansCellsPHPublic Health
    39. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin Chim Acta. 2020 Oct; 509:235-243. Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H, Miyashita S. PMID: 32533986; PMCID: PMC7832771.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCellsPHPublic Health
    40. Association Between Electroencephalogram-Derived Sleep Measures and the Change of Emotional Status Analyzed Using Voice Patterns: Observational Pilot Study. JMIR Form Res. 2020 Jun 09; 4(6):e16880. Miyashita H, Nakamura M, Svensson AK, Nakamura M, Tokuno S, Chung UI, Svensson T. PMID: 32515745; PMCID: PMC7312246.
      View in: PubMed   Mentions: 3     Fields:    
    41. Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass. Proc Natl Acad Sci U S A. 2020 06 23; 117(25):14386-14394. Kim SM, Taneja C, Perez-Pena H, Ryu V, Gumerova A, Li W, Ahmad N, Zhu LL, Liu P, Mathew M, Korkmaz F, Gera S, Sant D, Hadelia E, Ievleva K, Kuo TC, Miyashita H, Liu L, Tourkova I, Stanley S, Lizneva D, Iqbal J, Sun L, Tamler R, Blair HC, New MI, Haider S, Yuen T, Zaidi M. PMID: 32513693; PMCID: PMC7321982.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    42. Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate. Breast Cancer Res Treat. 2020 Jul; 182(2):381-388. Miyashita H, Cruz C, Malamud S. PMID: 32474744.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    43. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City. Int Urol Nephrol. 2020 Jul; 52(7):1405-1406. Yamada T, Mikami T, Chopra N, Miyashita H, Chernyavsky S, Miyashita S. PMID: 32458212; PMCID: PMC7250261.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    44. Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis. Breast Cancer Res Treat. 2020 Jun; 181(2):279-289. Miyashita H, Satoi S, Kuno T, Cruz C, Malamud S, Kim SM. PMID: 32318956.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    45. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020 08; 31(8):1088-1089. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C. PMID: 32330541; PMCID: PMC7172785.
      View in: PubMed   Mentions: 252     Fields:    Translation:HumansCellsPHPublic Health
    46. A Case of Dual Positive Glomerulonephritis With Plasma Cell Dyscrasia. Am J Med. 2020 08; 133(8):e436-e437. Yamada T, Miyashita H, Rasheed M, Chung M, Salem FE, Campbell KN. PMID: 32081655.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit. Clin Lymphoma Myeloma Leuk. 2020 05; 20(5):305-311. Bumma N, Nagasaka M, Hemingway G, Miyashita H, Chowdhury T, Kim S, Vankayala HM, Ahmed S, Jasti P. PMID: 32144026.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    48. Bacterial peritonitis in a patient with malignant ascites caused by pancreatic carcinoma: Case report and review of literature. J Infect Chemother. 2019 Jun; 25(6):473-476. Miyashita H, Okamoto K, Kobayashi T, Wakabayashi Y, Kitaura S, Ikeuchi K, Ishigaki K, Nakai Y, Okugawa S, Koike K, Moriya K. PMID: 30738726.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    49. Anti-obesity compounds in green leaves of Eucommia ulmoides. Bioorg Med Chem Lett. 2011 Mar 15; 21(6):1786-91. Hirata T, Kobayashi T, Wada A, Ueda T, Fujikawa T, Miyashita H, Ikeda T, Tsukamoto S, Nohara T. PMID: 21324693.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    50. Microkeratome assisted deep lamellar keratoprosthesis. Br J Ophthalmol. 2006 Jul; 90(7):826-9. Shimmura S, Miyashita H, Uchino Y, Taguchi T, Kobayashi H, Shimazaki J, Tanaka J, Tsubota K. PMID: 16597665; PMCID: PMC1857140.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    51. Bacterial cryptochrome and photolyase: characterization of two photolyase-like genes of Synechocystis sp. PCC6803. Nucleic Acids Res. 2000 Jun 15; 28(12):2353-62. Hitomi K, Okamoto K, Daiyasu H, Miyashita H, Iwai S, Toh H, Ishiura M, Todo T. PMID: 10871367; PMCID: PMC102721.
      View in: PubMed   Mentions: 37     Fields:    Translation:Cells
    52. Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults. Leuk Lymphoma. 1998 Mar; 29(1-2):161-70. Fujisawa S, Maruta A, Motomura S, Fukawa H, Kanamori H, Ogawa K, Matsuzaki M, Miyashita H, Harano H, Murata T, Sakai R, Mohri H, Kodama F, Okubo T. PMID: 9638985.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    53. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol. 1994 May; 89(5):762-6. Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Hashimoto M, Fukuchi S, Kosaka K. PMID: 8172153.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    54. Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism. 1993 Feb; 42(2):196-203. Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Kosaka K, Hara M. PMID: 7682643.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    55. [A case of spontaneous bacterial peritonitis with ascites caused by hypoproteinemia after a massive bleeding from a gastric ulcer]. Kansenshogaku Zasshi. 1993 Jan; 67(1):71-5. Guji A, Nishiya H, Haga T, Aoki M, Nozue N, Ono Y, Kunii O, Miyashita H. PMID: 8450277.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay. Metabolism. 1990 Sep; 39(9):925-30. Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inouye K, Kono M. PMID: 2202883.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    57. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs. Am J Vet Res. 1990 Apr; 51(4):605-10. Miyazawa Y, Sato T, Kobayashi K, Akahori F, Suzuki T, Miyashita H. PMID: 2327624.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    58. [A rapid diagnosis for periodontitis based on enzymatic activity of periodontopathic bacteria. Correlation between enzymatic activity, clinical periodontal parameters, and subgingival level of microorganisms]. Nihon Shishubyo Gakkai Kaishi. 1990 Mar; 32(1):241-8. Ohtake T, Sakurai C, Kurihara C, Minamizaki N, Kobayashi M, Miyashita H, Hasegawa K, Kobayashi T, Satoh E, Sugita N, et al. PMID: 2133686.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    59. [Clinical significance of islet cell antibody assay]. Nihon Rinsho. 1990 Feb; 48 Suppl:565-8. Kobayashi T, Miyashita H. PMID: 2192151.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. [Case of sarcoidosis with the initial symptom of nasal obstruction due to a nasal mucosal lesion--review of 41 reported cases in the literature]. Nihon Kyobu Shikkan Gakkai Zasshi. 1983 Jul; 21(7):672-8. Uetake T, Takahashi N, Suzuki T, Kudoh S, Hirayama M, Kimura H, Miyashita H, Motizuki T, Hongo O, Kaneda H. PMID: 6663907.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. [A case of female hypospadias]. Hinyokika Kiyo. 1983 Jan; 29(1):73-6. Kobayashi T, Watanabe H, Mishina T, Miyashita H. PMID: 6687142.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. CLINICAL FEATURE OF MYOCARDIAL INFARCTION IN JAPAN. Jpn Heart J. 1964 Nov; 5:497-511. YOSHITOSHI Y, HANAOKA W, NAGASAKA M, MIYASHITA H, YAMAGUCHI A, ITO T, WATANABE S, OSHIMA M, SHINOHARA Y. PMID: 14250894.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Hirotaka's Networks
    Concepts (289)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California